Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
BKD
|
Rita Johnson Mills
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,490 Added 5.1% |
$6,349
$2.55 p/Share
|
Oct 01
2020 |
|
DRQ
|
Terence Bartlett Jupp |
BUY
Grant, award, or other acquisition
|
Direct | 1,135 Added 3.53% |
-
|
Oct 01
2020 |
|
DRQ
|
John Lovoi |
BUY
Grant, award, or other acquisition
|
Direct | 2,334 Added 4.93% |
-
|
Oct 01
2020 |
|
DRQ
|
Steven L Newman |
BUY
Grant, award, or other acquisition
|
Direct | 946 Added 3.82% |
-
|
Oct 01
2020 |
|
DRQ
|
Amy B Schwetz |
BUY
Grant, award, or other acquisition
|
Direct | 946 Added 14.36% |
-
|
Oct 01
2020 |
|
DRQ
|
A P Shukis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 599 Added 2.87% |
-
|
Oct 01
2020 |
|
DRQ
|
Jeffrey J. Bird
President & CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 13.54% |
$240,300
$24.03 p/Share
|
Oct 01
2020 |
|
DRQ
|
Blake T. De Berry
CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 4.63% |
$240,300
$24.03 p/Share
|
Oct 01
2020 |
|
DRQ
|
Raj Kumar
VP - CFO |
SELL
Open market or private sale
|
Direct | 1,995 Reduced 10.12% |
$47,940
$24.03 p/Share
|
Oct 01
2020 |
|
DRQ
|
James C. Webster
VP, Gen Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 17.15% |
$240,300
$24.03 p/Share
|
Oct 01
2020 |
|
SPNT
|
David W Junius
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 214,592 Added 50.0% |
-
|
Oct 01
2020 |
|
VECO
|
William John Miller
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 5,972 Reduced 2.58% |
$69,693
$11.67 p/Share
|
Oct 01
2020 |
|
PFC
|
Charles D. Niehaus
Director |
BUY
Grant, award, or other acquisition
|
Direct | 604 Added 4.27% |
-
|
Oct 01
2020 |
|
CRNC
|
Mark J Gallenberger
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 9,734 Reduced 11.29% |
$484,169
$49.74 p/Share
|
Oct 01
2020 |
|
CRNC
|
Sanjay Dhawan
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 43,169 Reduced 9.79% |
$2,147,226
$49.74 p/Share
|
Oct 01
2020 |
|
CRNC
|
Leanne Fitzgerald
General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 3,123 Reduced 6.34% |
$155,338
$49.74 p/Share
|
Oct 01
2020 |
|
KREF
|
Christen E.J. Lee |
SELL
Payment of exercise price or tax liability
|
Direct | 25,057 Reduced 11.07% |
$414,192
$16.53 p/Share
|
Oct 01
2020 |
|
KREF
|
Mostafa Nagaty
CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,264 Reduced 11.99% |
$37,424
$16.53 p/Share
|
Oct 01
2020 |
|
KREF
|
W Patrick Mattson
President and COO |
SELL
Payment of exercise price or tax liability
|
Direct | 12,582 Reduced 11.94% |
$207,980
$16.53 p/Share
|
Oct 01
2020 |
|
KREF
|
Matthew A Salem
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 23,056 Reduced 12.29% |
$381,116
$16.53 p/Share
|
Oct 01
2020 |
|
MBUU
|
Michael Connolly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 356 Added 0.86% |
-
|
Oct 01
2020 |
|
MBUU
|
Mark W. Lanigan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 406 Added 0.98% |
-
|
Oct 01
2020 |
|
MBUU
|
Michael K. Hooks
Director |
BUY
Grant, award, or other acquisition
|
Direct | 432 Added 1.01% |
-
|
Oct 01
2020 |
|
NTUS
|
Benjamin Drew Davies
Executive VP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,664 Reduced 5.67% |
$45,794
$17.19 p/Share
|
Oct 01
2020 |
|
CDNA
|
Peter Maag |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 4.53% |
$816,400
$40.82 p/Share
|
Oct 01
2020 |
|
CDNA
|
Peter Maag |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 4.33% |
$114,000
$5.7 p/Share
|
Oct 01
2020 |
|
CDNA
|
Christine Cournoyer |
BUY
Grant, award, or other acquisition
|
Direct | 407 Added 3.32% |
-
|
Oct 01
2020 |
|
CDNA
|
Michael Goldberg |
BUY
Grant, award, or other acquisition
|
Direct | 1,081 Added 1.22% |
-
|
Oct 01
2020 |
|
CDNA
|
Ralph Snyderman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 370 Added 0.44% |
-
|
Oct 01
2020 |
|
CDNA
|
George Bickerstaff |
BUY
Grant, award, or other acquisition
|
Direct | 444 Added 0.49% |
-
|
Oct 01
2020 |
|
ADPT
|
Eric Dobmeier
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 100.0% |
$488,400
$48.84 p/Share
|
Oct 01
2020 |
|
ADPT
|
Eric Dobmeier
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 50.0% |
$63,200
$6.32 p/Share
|
Oct 01
2020 |
|
ADPT
|
Sharon Benzeno
Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct | 6,771 Reduced 100.0% |
$330,831
$48.86 p/Share
|
Oct 01
2020 |
|
ADPT
|
Sharon Benzeno
Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct | 6,771 Added 50.0% |
$45,975
$6.79 p/Share
|
Oct 01
2020 |
|
TRS
|
Jeffrey M Greene
Director |
BUY
Grant, award, or other acquisition
|
Direct | 451 Added 3.9% |
$10,396
$23.05 p/Share
|
Oct 01
2020 |
|
COMM
|
Claudius E. Iv Watts |
BUY
Grant, award, or other acquisition
|
Direct | 100,000 Added 30.89% |
-
|
Oct 01
2020 |
|
COMM
|
Charles L. Treadway
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 500,000 Added 50.0% |
-
|
Oct 01
2020 |
|
ALEX
|
Eric K Yeaman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,265 Added 5.52% |
-
|
Oct 01
2020 |
|
ALEX
|
John T Leong
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,530 Added 50.0% |
-
|
Oct 01
2020 |
|
SILK
|
Andrew S. Davis
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 6,635 Reduced 25.1% |
$435,256
$65.6 p/Share
|
Oct 01
2020 |
|
SILK
|
Andrew S. Davis
Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 6,635 Added 20.06% |
$9,687
$1.46 p/Share
|
Oct 01
2020 |
|
PI
|
Chris Ph.D. Diorio
CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 3,906 Added 1.36% |
-
|
Oct 01
2020 |
|
VBTX
|
Fallon William
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 672 Added 7.89% |
-
|
Oct 01
2020 |
|
VBTX
|
Gregory B Morrison
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 644 Added 4.54% |
-
|
Oct 01
2020 |
|
VBTX
|
Steven D. Lerner
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 644 Added 2.28% |
-
|
Oct 01
2020 |
|
VBTX
|
Manuel J Mehos
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 644 Added 0.12% |
-
|
Oct 01
2020 |
|
VBTX
|
Gordon Huddleston
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 923 Added 4.11% |
-
|
Oct 01
2020 |
|
VBTX
|
Ned N Fleming Iii
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,212 Added 9.45% |
-
|
Oct 01
2020 |
|
VBTX
|
William Don Ellis
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 644 Added 0.32% |
-
|
Oct 01
2020 |
|
VBTX
|
Blake Bozman
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 644 Added 0.82% |
-
|
Oct 01
2020 |